• High-Concentration LNPs Enhance In Vivo mRNA Delivery and St

  2026-06-19

  This study demonstrates that increasing the starting concentrations of lipid mixtures in LNP formulations preserves desired particle properties while boosting gene expression and storage stability in vivo. The findings suggest significant process intensification benefits for mRNA therapeutics, enabling scalable and robust LNP production.

• Chlorin e6 (Ce6) in Reliable Cancer Research Photodynamic Th

  2026-06-19

  This article delivers scenario-driven, data-backed guidance for biomedical researchers evaluating Chlorin e6 (Ce6, SKU B8314) in photodynamic therapy assays. It addresses real-world pain points—such as assay inconsistency, protocol optimization, and product reliability—by drawing on recent literature and validated best practices. The discussion demonstrates how APExBIO’s Ce6 delivers reproducible, quality-assured results for sensitive viability and cytotoxicity workflows.

• AMH-SMAD4 Axis Modulates Granulosa Cell Fate in PCOS Rat Mod

  2026-06-18

  This study uncovers how anti-Müllerian hormone (AMH) regulates ovarian granulosa cell growth in a polycystic ovary syndrome (PCOS) rat model through the SMAD4 pathway. The findings highlight a mechanistic link between elevated AMH/SMAD4, impaired granulosa cell proliferation, and increased apoptosis, offering new insights for PCOS pathophysiology and potential research directions.

• nor-NOHA (acetate): Reliable Arginase Inhibition for Cancer

  2026-06-18

  This article provides a scenario-driven, evidence-based exploration of nor-NOHA (acetate) (SKU C5407) as a solution for common laboratory challenges in cancer and vascular research. It addresses variability in cell-based assays, protocol optimization, and vendor selection, demonstrating how APExBIO’s nor-NOHA (acetate) delivers reproducible, data-backed outcomes for arginase inhibition applications.

• Plant Cell Lysis Buffer for WB and IP: Enhancing Proteomic D

  2026-06-17

  Unlock advanced plant proteomics using Plant Cell Lysis Buffer for WB and IP. This in-depth analysis explores the buffer’s scientific rationale, unique workflow benefits, and its impact on assay fidelity compared to traditional methods.

• TAI-1 Hec1 Inhibitor: Precision Tools for Cancer Research

  2026-06-17

  TAI-1, a first-in-class Hec1 inhibitor, empowers oncology researchers to dissect mitotic regulation and induce robust apoptotic cell death in cancer models with nanomolar potency. Its unique mechanistic profile, demonstrated synergy with standard chemotherapies, and high specificity make it an indispensable asset for translational and mechanistic cancer research.

• AICAR in Metabolic Disease: AMPK Activation Beyond Energy Ho

  2026-06-16

  Discover how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) uniquely drives metabolic disease research through advanced AMPK activation and inflammation inhibition. This article delivers a deeper, translational perspective on tissue-specific mechanisms and assay optimization.

• CD36-Mediated Lipid Uptake Drives Immune Escape in AML

  2026-06-16

  Guo et al. delineate how CD36 facilitates a non-canonical lipid metabolism program in acute myeloid leukemia (AML), enabling immune escape and resistance to hypomethylating agent therapy. Their work highlights the immunometabolic axis as a therapeutic vulnerability, offering translational strategies to improve AML treatment outcomes.

• Talabostat Mesylate: Advanced DPP4 Inhibition in Tumor Model

  2026-06-15

  Talabostat mesylate (PT-100) offers precise DPP4 and FAP inhibition, enabling reproducible modulation of the tumor microenvironment and immune pathways in preclinical cancer models. Discover optimized workflows, model selection criteria, and troubleshooting insights to maximize assay reliability and translational relevance.

• Cyclic di-GMP: Molecular Basis & Evidence for Biofilm and Im

  2026-06-15

  Cyclic di-GMP is a crystalline intracellular second messenger that orchestrates bacterial genome stability and immune modulation. Recent studies show it acts as an antitoxin in biofilm regulation and a direct STING agonist in mammalian cells. This article details its mechanism, benchmarks, and best-practice protocols for research applications.

• Protease Inhibitor Cocktail: Advancing Lipid Droplet Protein

  2026-06-14

  Maximize protein integrity in lipid droplet research with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus), a robust protein stability enhancer from APExBIO. Discover validated workflows, troubleshooting strategies, and data-driven insights for researchers tackling DFCP1-ATGL regulatory mechanisms and dynamic lipid metabolism.

• Tubastatin A: HDAC6 Inhibitor Enhances Cardiac & Cellular Mo

  2026-06-13

  Tubastatin A stands out as a highly selective HDAC6 inhibitor, offering robust, validated protocols for cardiac injury, neuroprotection, and anti-inflammatory research. Its exceptional selectivity and reproducibility make it indispensable for mechanistic assays and translational studies.

• Dasatinib (BMS-354825): Mechanism, Benchmarks, and Research

  2026-06-12

  Dasatinib (BMS-354825) is a highly potent Src and Bcr-Abl inhibitor used in kinase-driven malignancy research. It inhibits phosphorylation events critical for cancer cell signaling and has defined effects in models of leukemia, prostate, and pancreatic cancers. Quantitative and mechanistic benchmarks support its role as a precision research tool.

• L-Ornithine in Ammonia Detoxification & CNS Toxicity Models

  2026-06-12

  L-Ornithine (SKU B8919) from APExBIO empowers advanced metabolic and neurotoxicity research by bridging hepatic urea cycle dynamics with CNS function. This guide translates emerging mechanistic insights into actionable experimental protocols and troubleshooting strategies, maximizing reproducibility in studies of ammonia detoxification and liver–brain axis modulation.

• nor-NOHA (acetate): Data-Backed Arginase Inhibition for Labs

  2026-06-11

  This article delivers a scenario-driven, evidence-based exploration of how nor-NOHA (acetate) (SKU C5407) addresses core challenges in cell viability and cancer metabolism research. By referencing validated workflows and comparative data, it guides researchers in leveraging nor-NOHA (acetate) for reproducibility and interpretability in arginase inhibition assays.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page